Page 3 - Testing Consortium News Today

Trainer Amber Cobb was issued a seven-year suspension and $11,000 fine for multiple rule violations by the New Jersey Racing Commission. 

HISA Anti-Doping and Medication Control Program to Relaunch May 22, 2023, Under Enforcement of HIWU

Mofebutazone is an analogue of phenylbutazone exhibiting a non-steroidal anti-inflammatory (NSAID) mechanism of action.

The Horseracing Integrity & Welfare Unit (HIWU) is set to take over drug testing for U.S. Thoroughbred racing on March 27.

Ahead of the anticipated implementation of the Horseracing Integrity and Safety Authority’s (HISA) Anti-Doping and Medication Control Program (ADMC) on March 27, 2023, HISA and the Horseracing Integrity & Welfare Unit (HIWU) remind stakeholders of key changes to expect nationwide. These changes will go into effect immediately pending approval of the Program regulations by the Federal Trade Commission.

Lisa Lazarus, CEO of the Horseracing Integrity and Safety Program, gave a press briefing as the March 27 rollout of its Anti-Doping and Medication Control program approaches.

Withdrawal guidelines are for informational purposes only. It is advisable that this information should be used by horsemen in consultation with their attending veterinarian

Anti-Doping and Medication Control (ADMC) Program will strengthen equine welfare and enhance confidence in the fairness of the sport.

The anticipated March 27 implementation of HISA's Anti-Doping and Medication Control (ADMC) Program is approaching

The Maryland Thoroughbred Horsemen’s Association and Maryland Jockey Club will host an open forum for horsemen with Dr. Mary Scollay, Chief of Science for the Horseracing Integrity & Welfare Unit, to discuss the Horseracing Integrity and Safety Authority’s Anti-Doping and Medication Control Program.